GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 09/23 11:36:50 am
1414GBX -1.05%

GlaxoSmithKline ( '') (Form 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)

07/28/2021 | 02:24pm
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Sir Jonathan Symonds
b)
Position/status
Non-Executive Chairman
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£14.05
3,113.879
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr Charles Bancroft
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$39.35
1,469.711
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr Vindi Banga
b)
Position/status
Senior Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£14.05
645.018
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Anne Beal
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$39.35
122.409
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Vivienne Cox
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£14.05
600.534
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms Lynn Elsenhans
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$39.35
283.444
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Laurie Glimcher
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$39.35
1,049.794
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Jesse Goodman
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of notional ADSs under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$39.35
346.432
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr Urs Rohner
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of notional Ordinary Shares under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2021 to 30 June 2021
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£14.05
572.183
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2021-07-28
f)
Place of the transaction
N/A

Disclaimer

GSK - GlaxoSmithKline plc published this content on 28 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 July 2021 18:23:18 UTC.

© Publicnow 2021
Copier lien
All news about GLAXOSMITHKLINE PLC
4h ago
12h ago
15h ago
17h ago
1d ago